Neuberger Berman Group
AERI

Neuberger Berman Group’s Aerie Pharmaceuticals AERI Stock Holding History

Neuberger Berman Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-552,400
Closed -$16.3M – 1620
2019
Q2 		$16.3M Buy
552,400
+158,900
+40% +$6.12M 0.02% 654
2019
Q1 		$18.7M Buy
393,500
+7,000
+2% +$308K 0.02% 621
2018
Q4 		$14M Buy
386,500
+10,700
+3% +$502K 0.02% 661
2018
Q3 		$23.1M Buy
375,800
+34,500
+10% +$2.22M 0.03% 602
2018
Q2 		$23.1M Buy
341,300
+20,800
+6% +$1.16M 0.03% 607
2018
Q1 		$17.4M Buy
320,500
+59,000
+23% +$3.3M 0.02% 658
2017
Q4 		$15.6M Buy
261,500
+236,500
+946% +$14.3M 0.02% 693
2017
Q3 		$1.22M Buy
25,000
+12,500
+100% +$682K ﹤0.01% 1099
2017
Q2 		$657K Buy
+12,500
New +$582K ﹤0.01% 1250
2017
Q1 		– Sell
-11,500
Closed -$435K – 1660
2016
Q4 		$435K Sell
11,500
-7,000
-38% -$265K ﹤0.01% 1319
2016
Q3 		$698K Buy
+18,500
New +$408K ﹤0.01% 1191
2015
Q1 		– Sell
-27,500
Closed -$802K – 1675
2014
Q4 		$802K Buy
+27,500
New +$697K ﹤0.01% 1265

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Neuberger Berman Group's AERI Position: Q3 2019 in Review

Neuberger Berman Group sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 552,400 shares — an estimated $16.3M sold.

Neuberger Berman Group first reported a position in AERI in Q4 2014 and held it in 12 quarters. The position peaked at $23.1M in Q3 2018. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

  • Neuberger Berman Group reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Neuberger Berman Group sold 552,400 Aerie Pharmaceuticals shares in Q3 2019, an estimated $16.3M.
  • Neuberger Berman Group first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 12 quarters.
  • Neuberger Berman Group's Aerie Pharmaceuticals position peaked at $23.1M in Q3 2018.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on Neuberger Berman Group's 13F filing for Q3 2019, filed 13 Nov 2019.